3Naryshkin S.The false-negative fraction for Papanicolaou smears:how often are "abnormal" smears not detected by a "standard screening cytologist?" [J]. Arch Pathol Lab Med, 1997,121 (3) :270 - 272.
4Sherman ME, Kelly D. High-grade squamous intraepthelial lesions and invasive carcinoma following the report of three negative Papanicolaou smears screening failures of rapid progression [ J ]? Mod Pathol,1992,5(3) :337 - 342.
5Drijkoningen M, Meertens B, Lauweryns J. High-grade squmous intraepithelial lesion (CIN3) with extension into the endocervical clefts. Difficulty of cytologic differentiation from adenocarcinoma insitu[J]. Acta Cytol, 1996,40(5) :889 - 894.
6Diane S, Diane D, Robert K, et al. The 2001 Bethesda System:terminology for reporting results of cervical cytology[J]. JAMA,2002;287(16) : 2114 - 2119.
7Mark E, Sherman, MD, Sana O, et al. "ASCUS, Rule Out HSIL" :Cytologic features, histologic correlates, and human papillomavirus detection[J]. Intern J Med,2000,4(3) :7 - 13.
8Kinney WK, Manos MM, Hurley LB. Where's the high-grade cervical neoplasia? The importance of minimally abnormal Papanicolaou diagnoses [J]. Obstet Gynecol,1998,91(6):973-976.
9Kline MJ, Davey D. Atypical squamous cells of undetermined significance qualified: a follow-up study[J]. Diagn Cytopathol, 1996,14(4) :380 - 384.
10Taylor RT, Guerrieri JP, Nash JD, et al. Atypical cervical cytology.Colposcopic follow-up using the Bethesda system[J] .J Reprod Med,1993,38(6) :443 - 447.
